Resveratrol binding to human complement fragment 5a (
C5a
bioinformatics
circular dichroism
computer-aided drug design
fluorescence
glycoprotein(s)
molecular dynamics
neutraligands
receptors
resveratrol
Journal
Journal of biomolecular structure & dynamics
ISSN: 1538-0254
Titre abrégé: J Biomol Struct Dyn
Pays: England
ID NLM: 8404176
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
pubmed:
7
3
2020
medline:
29
6
2021
entrez:
6
3
2020
Statut:
ppublish
Résumé
Resveratrol (RSV), the active pharmaceutical ingredient (API) found in several fruits, nuts and marketed nutraceuticals is one of the promiscuous phytoalexin known to promote good health. The health benefits of RSV could be due to its antioxidant activity or its direct interaction with target proteins, resulting modulation of several cells signaling and inflammatory pathways. Among many of its disease preventing activities, RSV has been shown to ameliorate inflammation by directly binding the COX-1 and COX-2 enzymes, the established targets of common non-steroidal anti-inflammatory drugs (NSAIDs). As a follow up to our recent study, we have now identified that RSV can also directly target
Identifiants
pubmed: 32131707
doi: 10.1080/07391102.2020.1738958
doi:
Substances chimiques
Receptor, Anaphylatoxin C5a
0
Receptors, Complement
0
Complement C5a
80295-54-1
Resveratrol
Q369O8926L
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM